title: Creation New Patient Information Leaflets with Diabetes by Pharmacists and Assesment Conducted by Patients.
abstract: We created a draft of new patient information leaflets to ensure patients' proper use of drugs and to highlight safety issues and improvement plans extracted and proposed by small group discussions (SGD) with pharmacists. A total of 3 SGDs (participants: 15 pharmacists) were conducted with the aim of improving patient information leaflets for oral diabetes drugs. First, the disadvantages and advantages of the current instructions as well as requests for ideal patient information leaflets were obtained from participants. Conventional patient information leaflets that could be improved were useful to understand drug efficacy, adverse effects, and instructions for daily consumption of medicines, and to encourage patients to re-check drugs at home and inform their family of the measures to be taken in the case of adverse effects from the standpoint of patients. However, some disadvantages arose; for example, the instructions were difficult to read because of small lettering and illustrations and too much text. It was not tailored for individual patients, and descriptions about serious adverse effects caused patients much anxiety. Therefore, we have created a draft of new patient information leaflets with diabetes that are simpler and easier to understand and use concise wording and illustrations that are impactful.
authors.affiliation: Sumitomo Dainippon Pharma Co., Ltd.
authors.forename: Motoharu
authors.initials: M
authors.lastname: Arai
authors.forename: Kazuto
authors.initials: K
authors.lastname: Maeda
authors.forename: Hiroki
authors.initials: H
authors.lastname: Satoh
authors.forename: Akiko
authors.initials: A
authors.lastname: Miki
authors.forename: Yasufumi
authors.initials: Y
authors.lastname: Sawada
mesh_terms: D060433:Administration, Ophthalmic; D001007:Anxiety; D002792:Cholestyramine Resin; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000523:psychology*; D055991:Health Records, Personal; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D010174:Pamphlets; D010349:Patient Compliance; D010353:Patient Education as Topic / Q000379:methods*; D010361:Patients / Q000523:psychology*; D010595:Pharmacists
chemical_list: D007004:Hypoglycemic Agents; D002792:Cholestyramine Resin